Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117]
Ann Oncol. 2022 Sep;33(9):988.
doi: 10.1016/j.annonc.2022.05.004.
Epub 2022 Jul 6.
1 Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
2 Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
3 University Hospital of Salamanca, IBSAL, Cancer Research Center, Salamanca, Spain.
4 Department of Hematology, Amsterdam, UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, Netherlands.
5 Leeds Cancer Centre and University of Leeds, Leeds, UK.
6 Department of Hematology, University Hospital Leuven, Leuven, Belgium.
7 Faculty of Medicine, University Hospital Ostrava, Ostrava, Czech Republic.
8 Oslo Myeloma Center, Oslo, University Hospital, Oslo; KG Jebsen Center for B Cell Malignancies, University of Oslo, Oslo, Norway.
9 IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia "Seràgnoli", Bologna, Italy; Dipartimento di Medicina Specialistica, Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
10 University Hospital Heidelberg, Internal Medicine V and National Center for Tumor Diseases (NCT), Heidelberg, Germany.
11 Hôpital Claude Huriez, Lille University Hospital, Lille, France.
12 Department of Internal Medicine II, University Hospital Wurzburg, Wurzburg, Germany.
13 Division of Hematology, University of Torino, AOU Città della Salute e della Scienza di Torino, Torino, Italy.
14 Clinica Universidad de Navarra, CIMA, IDISNA, CIBERONC, Pamplona, Spain.
15 Erasmus Medical Center Cancer Institute, Rotterdam, Netherlands.
16 Department of Oncology and Hematology, Kantonsspital Graubünden, Chur, Switzerland.